Literature DB >> 12442006

A new transurethral resection system: operating in saline environment precludes obturator nerve reflexes.

Hiroaki Shiozawa1, Taku Aizawa, Takaaki Ito, Makoto Miki.   

Abstract

PURPOSE: We developed a transurethral resection system comprising a uniquely designed resectoscope and high frequency wave generator. The obturator nerve is free of electrical stimulation during transurethral resection since high frequency current is delivered via a resection loop to the sheath of the resectoscope in saline irrigation. Preclinical verification of the system was performed in an animal model to ensure its efficacy and operational safety.
MATERIALS AND METHODS: The swine bladder wall was transurethrally resected using the system in a saline environment. Results were subsequently compared with data on identical resection performed with the conventional system in sorbitol solution irrigation. Electrolyte contents were measured after resection for comparative evaluation with corresponding pre-resection data. Also, the depth of heat degeneration was measured in resected tissue.
RESULTS: No additional skills were required for bladder resection performed with the new system versus the conventional system. No lower limb adductor contraction was noted except minimal creeping during resection of a site close to the urethra. There were no apparent anomalies of blood electrolytes after transurethral resection. No difference was observed in the mean depth of heat degenerated tissues compared with the conventional system.
CONCLUSIONS: The newly developed transurethral resection system was effective in a saline irrigated environment, which inhibited the obturator nerve reflex when applied in an animal model. This finding suggests promising potential for the system as a safe and cost-effective alternative compared with conventional transurethral resection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12442006     DOI: 10.1097/01.ju.0000031402.89232.e1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Best practice in the treatment of nonmuscle invasive bladder cancer.

Authors:  Anastasios Anastasiadis; Theo M de Reijke
Journal:  Ther Adv Urol       Date:  2012-02

Review 2.  [Transurethral resection for benign prostatic hyperplasia. current developments].

Authors:  M Alschibaja; F May; U Treiber; R Paul; R Hartung
Journal:  Urologe A       Date:  2005-05       Impact factor: 0.639

3.  [Transurethral resection of bladder tumours in sodium chloride solution].

Authors:  C Brunken; H Qiu; R Tauber
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

4.  Efficacy of ultrasound-guided obturator nerve block in transurethral surgery.

Authors:  Ahmed Thallaj; Dany Rabah
Journal:  Saudi J Anaesth       Date:  2011-01

5.  Effectiveness of spinal anesthesia combined with obturator nerve blockade in preventing adductor muscle contraction during transurethral resection of bladder tumor.

Authors:  Cyrus Emir Alavi; Seyed Alaeddin Asgari; Siavash Falahatkar; Siamak Rimaz; Mohammadreza Naghipour; Hossein Khoshrang; Mehdi Jafari; Nadia Herfeh
Journal:  Turk J Urol       Date:  2017-12-01

6.  Bipolar resection of the bladder and prostate--initial experience with a newly developed regular sized loop resectoscope.

Authors:  Thorsten Bach; Thomas R W Herrmann; Christian Cellarius; Bogdan Geavlete; Andreas J Gross; Marian Jecu
Journal:  J Med Life       Date:  2009 Oct-Dec

7.  Comparison of inguinal versus classic approach for obturator nerve block in patients undergoing transurethral resection of bladder tumors under spinal anesthesia.

Authors:  Srilata Moningi; Padmaja Durga; Gopinath Ramachandran; Pisapati Venkata Lakshmi Narasimha Murthy; Rami Reddy Chilumala
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-01

8.  Risk assessment of neuromuscular stimulation by energy-based transurethral resection devices: an ex vivo test standard.

Authors:  Ulrich Biber; Ovidiu Jurjut; Markus D Enderle; Wilhelm K Aicher
Journal:  BMC Urol       Date:  2020-05-27       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.